SK bioscience Joins Korea's National Initiative to Develop Avian Influenza Vaccine Amid Rising Pandemic Threats
Company aims to develop a bird flu vaccine with rapid mass production and variant responsiveness. SK
{fullname}
About author
You should write because you love the shape of stories and sentences and the creation of different words on a page.
View all posts
Related posts
---
SK bioscience Initiates Global Clinical Trials of mRNA Japanese Encephalitis Vaccine Candidate
SK bioscience's first mRNA vaccine candidate enters Phase 1/2 clinical trials in Australia and New Zealand,
---
SK bioscience Secures Funding to Advance RSV Preventive Antibody Development with RIGHT Foundation Support
Largest-ever grant from RIGHT Foundation to accelerate Phase 1b clinical trial of RSV preventive antibody
---
SK bioscience Secures First UNICEF Procurement Contract Improving Vaccine Access
First UNICEF procurement contract strengthens SK bioscience's presence in global public procurement markets
